Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gottlieb's Confirmation: Will Industry Ties Remain A Big Deal After The Hearing?

Executive Summary

The US FDA commissioner does not generally get involved with day-to-day activities, former FDA chiefs say, but perception of bias could be lasting problem.


Related Content

AbbVie Hikes Doc Payments By 135%, Merck By 86% As BMS, J&J Cut Spending
Gottlieb's FDA: Specialized Groups Could Create Review Consistency, Speed
US FDA Commissioner Confirmation: Gottlieb To Get Questions On Approval Standards, Ties To Industry
Gottlieb Nomination As US FDA Chief Could Signal Changes To Generic Approval Process
Woodcock Tries To Calm US FDA Staff Fears About Trump
Political Appointees Shouldn't Influence Approval Decisions, Califf Says
Sarepta's Eteplirsen Approved After Contentious Internal FDA Debate
Califf’s Confirmation Fall-Out: Should Sponsors Worry About Research Contracts?
Califf Has Several Industry Ties To Sever Before Joining FDA
HHS Overrules FDA On Plan B OTC, Sends Teva Back To Drawing Board


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts